ARIA Trade on Nov 25, 2013 09:34 from joshua02194: Tradervue User Stock Trades.

"The impetus for this was a ruling from the European drug regulator that allows Ariad to continue selling its leukemia drug with some restrictions. The threat that the company would have to withdraw the drug had caused shares to slide 88% since October. Looks like the company dodged a bullet there."

Done right: Bot when price broke higher from a retracement after a gap up on huge volume. Timing was good

Done wrong: did not trail profits and only sell after a final failed flag. Should have let the price hit stop loss instead of exiting prematurely @ $4.26

Stop monitoring price @ 11:00 resulting in missing a huge run beginning @ 12:00